SEC Form 4 · accession 0001569706-18-000003
NYMOX PHARMACEUTICAL CORP · NYMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Averback
Officer — CEO · Director · 10% Owner
Period of report
Oct 26, 2018
Accepted (ET)
Nov 6, 2018 · 5:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001018735
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Restricted Common | Oct 26, 2018 | S | 100,000 | $1.75 | D | 23,331,448 | D |
Table II — derivative securities
No Table II lines on this filing.